Chelsea Counsel Company’s Eli Lilly LLY Stock Holding History

Chelsea Counsel Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$323K	Sell	351 -30	-8%	-$30.4K	0.14%	85
2025 Q4	$409K	Hold	381	–	–	0.18%	76
2025 Q3	$291K	Sell	381 -199	-34%	-$148K	0.13%	93
2025 Q2	$452K	Sell	580 -25	-4%	-$19.4K	0.22%	72
2025 Q1	$500K	Sell	605 -925	-60%	-$770K	0.27%	60
2024 Q4	$1.18M	Buy	1,530 +100	+7%	+$82.8K	0.61%	38
2024 Q3	$1.27M	Buy	1,430 +1,000	+233%	+$899K	0.62%	37
2024 Q2	$389K	Hold	430	–	–	0.19%	73
2024 Q1	$335K	Hold	430	–	–	0.19%	70
2023 Q4	$251K	Hold	430	–	–	0.13%	88
2023 Q3	$231K	Hold	430	–	–	0.12%	96
2023 Q2	$202K	Hold	430	–	–	0.1%	98
2023 Q1	$148K	Hold	430	–	–	0.07%	106
2022 Q4	$157K	Buy	+430	New	+$152K	0.08%	105
2015 Q4	–	Sell	-2,528	Closed	-$212K	–	146
2015 Q3	$212K	Hold	2,528	–	–	0.05%	146
2015 Q2	$211K	Buy	+2,528	New	+$193K	0.05%	150

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Chelsea Counsel Company's LLY Position: Q1 2026 in Review

Chelsea Counsel Company reduced its Eli Lilly (LLY) stake by 7.9% in Q1 2026, selling an estimated $30.4K and leaving 351 shares worth $323K. The position accounts for 0.14% of the portfolio, ranked #85.

Chelsea Counsel Company first reported a position in LLY in Q2 2015 and has held it in 16 quarters since. The position peaked at $1.27M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Chelsea Counsel Company held 351 shares of Eli Lilly worth $323K as of Q1 2026.
Chelsea Counsel Company sold 30 Eli Lilly shares in Q1 2026, an estimated $30.4K.
Eli Lilly made up 0.14% of Chelsea Counsel Company's portfolio in Q1 2026, its #85 holding.
Chelsea Counsel Company first reported a position in Eli Lilly in Q2 2015 and has held it in 16 quarters since.
Chelsea Counsel Company's Eli Lilly position peaked at $1.27M in Q3 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.